Assignee
RENAGADE THERAPEUTICS MAN INC
US·6 granted patents·10 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
16 records- 0179US12264328B2Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Apr 1, 2025·0 cites·16 claims
- 0278US12054739B2Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Aug 6, 2024·0 cites·30 claims
- 0377US2025154533A1Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 0475US11866728B2Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Jan 9, 2024·0 cites·30 claims
- 0568US11773061B2Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Oct 3, 2023·0 cites·30 claims
- 0668US2024182412A1Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 0766US12545636B2Acyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Feb 10, 2026·0 cites·17 claims
- 0865US2024084274A1Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 0964US2025154102A1Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1064US2024130969A1Lipid nanoparticles and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 1164US2025313525A1Constrained lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1263US12215068B2Constrained lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Feb 4, 2025·0 cites·30 claims
- 1363US2026062700A1Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 1463US2024200118A1Compositions and methods for optimizing tropism of delivery systems for rnaRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1561US2025340901A1Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2025·Application pending·0 cites
- 1660US2025367322A1Nucleobase editing system and method of using same for modifying nucleic acid sequencesRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →